Emerging Treatment Approaches and Multidisciplinary Management of Unresectable Stage III Non-Small Cell Lung Cancer - Episode 1
Defining Resectability in Stage III NSCLC: Addressing Key Controversies
Panelists discuss how the resectability of stage III non-small cell lung cancer tumors remains controversial, particularly regarding the role of surgery in multi-station N2 disease and the optimal sequencing of multimodality therapy.
Video Player is loading.
Video content above is prompted by the following:
- There is some debate about which tumors can be resected in stage III NSCLC. Can you describe the areas of controversy and how you determine whether a tumor is resectable?
Related Content:
